Early Prediction of Tacrolimus-Induced Tubular Toxicity in Pediatric Refractory Nephrotic Syndrome Using Machine

Xiaolan Mo1,2, Xiujuan Chen3, Chifong Ieong2

  • 1Department of Pharmacy, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Frontiers in Pharmacology
|September 13, 2021
PubMed

Insights

This study developed a machine learning model to predict tacrolimus (TAC)-induced nephrotoxicity in children with nephrotic syndrome (NS). The model uses genetic factors to identify patients at risk, enabling early intervention and optimized treatment strategies.

Area of Science:

  • Pharmacogenomics
  • Nephrology
  • Machine Learning in Medicine

Background:

  • Tacrolimus (TAC) is crucial for nephrotic syndrome (NS) but causes variable nephrotoxicity, potentially leading to end-stage renal disease.
  • Effective early prediction models for TAC-induced nephrotoxicity, particularly in NS patients, are lacking.
  • This study addresses the need for predictive tools to mitigate TAC-related kidney damage.

Purpose of the Study:

  • To develop and validate a machine learning model for predicting TAC-induced tubular toxicity in children with NS.
  • To identify key clinical and genetic variables associated with TAC nephrotoxicity.
  • To enable personalized treatment strategies for NS patients receiving TAC.

Main Methods:

  • A retrospective cohort of 218 NS children was used for model development, with prospective validation in 11 children.
  • Machine learning algorithms (XGBoost, GBDT, ET, RF, LR) were employed.
  • Urine N-acetyl-β-D-glucosaminidase (NAG) levels served as the indicator for renal tubular toxicity, alongside 47 clinical and 244 genetic features.

Main Results:

  • The XGBoost model demonstrated the best performance with 75% sensitivity, 77.8% specificity, 77.3% accuracy, and 78.9% AUC.
  • Four genetic variables (TRPC6 rs3824934_GG, HSD11B1 rs846910_AG, MAP2K6 rs17823202_GG, SCARB2 rs6823680_CC) were significant predictors.
  • The model effectively predicted TAC-induced nephrotoxicity in NS patients.

Conclusions:

  • A robust, machine learning-based predictive model for TAC-induced nephrotoxicity in NS patients was successfully developed and validated.
  • The model, utilizing genetic factors, allows for pre-administration risk assessment.
  • This tool can guide physicians in optimizing TAC treatment regimens and preventing kidney damage.

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
31
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
39
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
92
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
425
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
425
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
24